← All indications
Chordoma
A malignant tumor arising from the embryonic remains of the notochord. It is also called chordocarcinoma, chordoepithelioma, and notochordoma. (Dorland, 27th ed)
Drugs by status
Phase 2 trials (31)
- F 18-fluoroazomycin arabinoside
- afatinib
- anlotinib
- aldoxorubicin
- atezolizumab
- avelumab
- gi-6301
- imatinib
- lapatinib
- nivolumab
- pembrolizumab
- palbociclib
- pemetrexed
- ipilimumab
- sirolimus
- cyclophosphamide
- cetuximab
- dasatinib
- tazemetostat
- vinblastine
- zoledronic acid
- etbx-051
- etbx-061
- nk-92
- fludeoxyglucose f-18
- camrelizumab
- relatlimab
- nogapendekin alfa inbakicept
- tiragolumab
- eras-601
- +1 more
Phase 1 trials (9)
Organizations
Organization Involved with Phase 2 Indications (21)
- Bristol-Myers Squibb
- Novartis
- NantWorks
- Sarcoma Oncology Research Center, LLC
- Aadi, LLC
- Boehringer Ingelheim
- Epizyme, Inc.
- National Cancer Institute (NCI)
- Harvard University
- Sarcoma Alliance for Research through Collaboration
- Southwest Oncology Group
- University of Heidelberg
- University of Michigan
- Peking University
- University of California, Los Angeles
- Leiden University
- Nationales Centrum fur Tumorerkrankungen
- Curie Institute
- Chordoma Foundation
- People's Liberation Army of China
- Chinese Academy of Medical Sciences
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (4)